A phase II/III randomized study in advanced non-small cell lung cancer (NSCLC) with first-line combination versus sequential gemcitabine and docetaxel: second interim study results

被引：0
|
作者：
Mueller, Annette [1 ]
Thatcher, Nick [2 ]
Kortsik, Cornelius [3 ]
Koschel, Gabriele [4 ]
Spengler, Werner [5 ]
Pitz, Lothar R. [6 ]
Mezger, Joerg [7 ]
Manegold, Christian [1 ]
机构：
[1] Thoraxklin, Heidelberg, Germany
[2] Christie Hosp Ward 12 Lung Canc, Manchester, Lancs, England
[3] KH St Hildegardis, Mainz, Germany
[4] AKH Hamburg, Hamburg, Germany
[5] KH Schillerhohe, Gerlingen, Germany
[6] Zent Einheit Biostat C060, German Canc Res Ctr DKFZ, Heidelberg, Germany
[7] St Vincent Kliniken, Karlsruhe, Germany
来源：
ANNALS OF ONCOLOGY | 2004年 / 15卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：168 / 169
页数：2
相关论文
共 50 条
  • [1] A phase II/III randomized study in advanced non-small-cell lung cancer (NSCLC) with first-line combination versus sequential gemcitabine and docetaxel:: second interim study results
    Müller, A
    Thatcher, N
    Kortsik, C
    Koschel, G
    Spengler, W
    Pitz, LR
    Mezger, J
    Manegold, C
    [J]. LUNG CANCER, 2004, 45 : S76 - S76
  • [2] A phase II/III randomized study in advanced non-small cell lung cancer (NSCLC) with first line combination versus sequential gemcitabine and docetaxel: Interim study results.
    Mueller, A
    Thatcher, N
    Kortsik, C
    Koschel, G
    Spengler, W
    Pilz, L
    Mezger, J
    Manegold, C
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (14) : 640S - 640S
  • [3] Sequential versus concomitant administration of docetaxel and gemcitabine as first-line treatment of advanced non-small cell lung cancer (NSCLC):: results of a phase II/III randomised study
    Manegold, C.
    Thatcher, N.
    Kortsik, C.
    Koschel, G.
    Spengler, W.
    Mezgar, J.
    Schott von Romer, K.
    Pilz, L.
    [J]. EJC SUPPLEMENTS, 2005, 3 (02): : 326 - 326
  • [4] Docetaxel-gemcitabine versus cisplatin-gemcitabine plus sequential docetaxel in the first-line treatment of metastatic non-small cell lung cancer (NSCLC): interim results of a randomized Phase II trial
    Binder, Daniel
    Beinert, Thomas
    Schweisfurth, Hans
    Grah, Christian
    Temmestfeld-Wollbrueck, Bettina
    Schaeper, Christoph
    Mueller-Hagen, Gerit
    Schuermann, Dirk
    Suttorp, Norbert
    [J]. ANNALS OF ONCOLOGY, 2004, 15 : 178 - 178
  • [5] Gemcitabine and docetaxel as concomitant or sequential first-line therapy of advanced non-small cell lung cancer:: Updated results of a randomized study
    Manegold, C
    Thatcher, N
    Kortsik, C
    Koschel, G
    Spengler, W
    Mezger, J
    Müller, A
    Piiz, L
    [J]. LUNG CANCER, 2005, 49 : S36 - S36
  • [6] Phase II study of docetaxel and oxaliplatin in combination with bevacizumab as first-line therapy for advanced non-small cell lung cancer (NSCLC).
    Raez, L. E.
    Brito, R.
    Kobina, S.
    Perdekamp, M. G.
    Karr, M.
    Santos, E. S.
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2010, 28 (15)
  • [7] A phase II study of sequential docetaxel and gemcitabine followed by docetaxel and carboplatin as first-line therapy for non-small cell lung cancer
    Eleni M. Karapanagiotou
    Adrianni Charpidou
    Ifigenia Tzannou
    Kalliopi Dilana
    Elias Kotteas
    Ioannis Tourkantonis
    Epaminondas Kosmas
    Aspasia Provata
    Kostas Syrigos
    [J]. Medical Oncology, 2008, 25 : 303 - 308
  • [8] A phase II study of sequential docetaxel and gemcitabine followed by docetaxel and carboplatin as first-line therapy for non-small cell lung cancer
    Karapanagiotou, Eleni M.
    Charpidou, Adrianni
    Tzannou, Ifigenia
    Dilana, Kalliopi
    Kotteas, Elias
    Tourkantonis, Ioannis
    Kosmas, Epaminondas
    Provata, Aspasia
    Syrigos, Kostas
    [J]. MEDICAL ONCOLOGY, 2008, 25 (03) : 303 - 308
  • [9] A phase II/III randomized study in advanced non-small cell lung cancer (NSCLC) with first line combination versus sequential gemcitabine (G) and docetaxel (D):: Update on quality of life (QoL), toxicity, and costs.
    Manegold, C
    Thatcher, N
    Kortsik, C
    Koschel, G
    Spengler, W
    Mezger, J
    Müller, A
    Pilz, LR
    [J]. JOURNAL OF CLINICAL ONCOLOGY, 2005, 23 (16) : 634S - 634S
  • [10] Phase II study of first-line sequential chemotherapy with gemcitabine-carboplatin followed by docetaxel in patients with advanced non-small cell lung cancer
    Chiappori, A
    Simon, G
    Williams, C
    Haura, E
    Rocha-Lima, C
    Wagner, H
    Bepler, G
    Antonia, S
    [J]. ONCOLOGY, 2005, 68 (4-6) : 382 - 390
12345